Key statistics

On Wednesday, Novo Nordisk A/S (NVO:NYQ) closed at 61.10, -5.74% below its 52-week high of 64.82, set on Feb 06, 2020.
52-week range
46.47May 16 201964.82Feb 06 2020
Markit short selling activity
Previous close61.10
Average volume1.06m
Shares outstanding1.86bn
Free float1.17bn
P/E (TTM)25.62
Market cap114.09bn USD
EPS (TTM)2.38
Annual div (ADY)1.23
Annual div yield (ADY)2.02%
Div ex-dateAug 16 2019
Div pay-dateAug 27 2019
Next div ex-dateMar 27 2020
Next div pay-dateApr 07 2020
Data delayed at least 15 minutes, as of Feb 26 2020 23:30 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.